These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 38451434

  • 21. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
    Su C, Yang X, Lou J.
    Brain Res; 2016 Aug 01; 1644():98-106. PubMed ID: 27173998
    [Abstract] [Full Text] [Related]

  • 22. Motor deficits and beta oscillations are dissociable in an alpha-synuclein model of Parkinson's disease.
    Brys I, Nunes J, Fuentes R.
    Eur J Neurosci; 2017 Aug 01; 46(3):1906-1917. PubMed ID: 28370471
    [Abstract] [Full Text] [Related]

  • 23. Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease.
    Ahmad MH, Fatima M, Ali M, Rizvi MA, Mondal AC.
    Neuropharmacology; 2021 Dec 15; 201():108831. PubMed ID: 34655599
    [Abstract] [Full Text] [Related]

  • 24. ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson's Disease.
    Cóppola-Segovia V, Cavarsan C, Maia FG, Ferraz AC, Nakao LS, Lima MM, Zanata SM.
    Mol Neurobiol; 2017 Oct 15; 54(8):5798-5806. PubMed ID: 27660269
    [Abstract] [Full Text] [Related]

  • 25. miR-486-3p Influences the Neurotoxicity of a-Synuclein by Targeting the SIRT2 Gene and the Polymorphisms at Target Sites Contributing to Parkinson's Disease.
    Wang Y, Cai Y, Huang H, Chen X, Chen X, Chen X, Mai H, Li X, Zhao J, Yang J, Fan W, Tang P, Chen Y, Li K, Cui L.
    Cell Physiol Biochem; 2018 Oct 15; 51(6):2732-2745. PubMed ID: 30562735
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. MALAT1 Mediates α-Synuclein Expression through miR-23b-3p to Induce Autophagic Impairment and the Inflammatory Response in Microglia to Promote Apoptosis in Dopaminergic Neuronal Cells.
    Geng X, Zou Y, Li S, Qi R, Yu H, Li J.
    Mediators Inflamm; 2023 Oct 15; 2023():4477492. PubMed ID: 37064502
    [Abstract] [Full Text] [Related]

  • 28. Multifactorial theory applied to the neurotoxicity of paraquat and paraquat-induced mechanisms of developing Parkinson's disease.
    Zhang XF, Thompson M, Xu YH.
    Lab Invest; 2016 May 15; 96(5):496-507. PubMed ID: 26829122
    [Abstract] [Full Text] [Related]

  • 29. Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.
    Zhao F, Wang W, Wang C, Siedlak SL, Fujioka H, Tang B, Zhu X.
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun 15; 1863(6):1359-1370. PubMed ID: 28215578
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
    He Q, Koprich JB, Wang Y, Yu WB, Xiao BG, Brotchie JM, Wang J.
    Mol Neurobiol; 2016 May 15; 53(4):2258-68. PubMed ID: 25972237
    [Abstract] [Full Text] [Related]

  • 32. Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor/α-synuclein axis in atrazine-induced Parkinson's disease by peripheral blood and brain microRNA profiling.
    Li B, Jiang Y, Xu Y, Li Y, Li B.
    Chemosphere; 2019 Oct 15; 233():542-548. PubMed ID: 31185338
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A, Rota D, Debetto P, Peroni D, Guidolin D, Negro A, Skaper SD, Giusti P.
    Neurobiol Dis; 2008 Apr 15; 30(1):8-18. PubMed ID: 18313315
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration.
    Acosta G, Race N, Herr S, Fernandez J, Tang J, Rogers E, Shi R.
    Mol Cell Neurosci; 2019 Jul 15; 98():140-154. PubMed ID: 31201929
    [Abstract] [Full Text] [Related]

  • 38. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease.
    Zhang J, Dongwei Zhou, Zhang Z, Xinhui Qu, Kunwang Bao, Guohui Lu, Jian Duan.
    Biochem Biophys Res Commun; 2019 Nov 19; 519(4):740-746. PubMed ID: 31547989
    [Abstract] [Full Text] [Related]

  • 39. Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease.
    Kumar V, Singh D, Singh BK, Singh S, Mittra N, Jha RR, Patel DK, Singh C.
    Mol Cell Biochem; 2018 Jul 19; 444(1-2):149-160. PubMed ID: 29198021
    [Abstract] [Full Text] [Related]

  • 40. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.
    Alvarez-Erviti L, Seow Y, Schapira AH, Rodriguez-Oroz MC, Obeso JA, Cooper JM.
    Cell Death Dis; 2013 Mar 14; 4(3):e545. PubMed ID: 23492776
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.